Novel molecular targets regulated by tumor suppressors microRNA-1 and microRNA-133a in bladder cancer

International Journal of Oncology

Volumn 40, Issue 6, 2012, Pages 1821-1830

  Yamasaki, Takeshi ^a   Yoshino, Hirofumi ^a   Enokida, Hideki ^a   Hidaka, Hideo ^a   Chiyomaru, Takeshi ^a   Nohata, Nijiro ^b   Kinoshita, Takashi ^b   Fuse, Miki ^b   Seki, Naohiko ^b   Nakagawa, Masayuki ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

Bladder cancer; MicroRNA; miR 1; miR 133; Prothymosin ; Purine nucleoside phosphorylase

Indexed keywords

CASPASE 3; CASPASE 7; LUCIFERASE; MESSENGER RNA; MICRORNA; MICRORNA 1; MICRORNA 133A; PROTHYMOSIN ALPHA; PURINE NUCLEOSIDE PHOSPHORYLASE; UNCLASSIFIED DRUG;

ADULT; AGED; APOPTOSIS; ARTICLE; BLADDER CANCER; BLADDER EPITHELIUM; CANCER CELL CULTURE; CARCINOGENESIS; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; ENZYME ACTIVATION; FEMALE; GENE CONTROL; GENE EXPRESSION; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; BASE SEQUENCE; CASPASES; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; MALE; MICRORNAS; MIDDLE AGED; PROTEIN PRECURSORS; PURINE-NUCLEOSIDE PHOSPHORYLASE; RNA INTERFERENCE; THYMOSIN; TISSUE ARRAY ANALYSIS; URINARY BLADDER NEOPLASMS;

EID: 84861767427     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2012.1391     Document Type: Article

References (34)

1. Siegel R, Ward E, Brawley O and Jemal A: Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61: 212-236, 2011.
2. Herr H, Konety B, Stein J, Sternberg CN and Wood DP Jr: Optimizing outcomes at every stage of bladder cancer:do we practice it? Urol Oncol 27: 72-74, 2009.
3. Lagos-Quintana M, Rauhut R, Lendeckel W and Tuschl T: Identification of novel genes coding for small expressed RNAs. Science 294: 853-858, 2001. (Pubitemid 33032103)
4. Nasser MW, Datta J, Nuovo G, Kutay H, Motiwala T, Majumder S, Wang B, Suster S, Jacob ST and Ghoshal K: Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis 31 by miR-1. J Biol Chem 283: 33394-33405, 2008.
5. Schickel R, Boyerinas B, Park SM and Peter ME: MicroRNAs:key players in the immune system, differentiation, tumorigenesis and cell death. Oncogene 27: 5959-5974, 2008.
6. Chhabra R, Dubey R and Saini N: Cooperative and individualistic functions of the microRNAs in the miR-23a-27a-24-2 cluster and its implication in human diseases. Mol Cancer 9: 232, 2010.
7. Zhang ZW, An Y and Teng CB: The roles of miR-17-92 cluster in mammal development and tumorigenesis. Yi Chuan 31: 1094-1100, 2009.
8. Di Leva G, Gasparini P, Piovan C, Nqankeu A, Garofalo M, Taccioli C, Iorio MV, Li M, Volinia S, Alder H, Nakamura T, Nuovo G, Liu Y, Nephew KP and Croce CM: MicroRNA cluster 221-222 and estrogen receptor alpha interactions in breast cancer. J Natl Cancer Inst 102: 706-721, 2010.
9. Aqeilan RI, Calin GA and Croce CM: miR-15a and miR-16-1 in cancer: discovery, function and future perspectives. Cell Death Differ 17: 215-220, 2010.
10. Chiyomaru T, Enokida H, Tatarano S, Kawahara K, Uchida Y, Nishiyama K, Fujimura L, Kikkawa N, Seki N and Nakagawa M: miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer. Br J Cancer 102: 883-891, 2010.
11. Uchida Y, Chiyomaru T, Enokida H, Kawakami K, Tatarano S, Kawahara K, Nishiyama K, Seki N and Nakagawa M: MiR-133a induces apoptosis through direct regulation of GSTP1 in bladder cancer cell lines. Urol Oncol: Mar 9, 2011 (Epub ahead of print).
12. Datta J, Kutay H, Nasser MW, Nuovo GJ, Wang B, Majumder S, Liu CG, Volinia S, Croce CM, Schmittgen TD, Ghoshal K and Jacob ST: Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesis. Cancer Res 68: 5049-5058, 2008.
13. Yan D, Dong Xda E, Chen X, Wang L, Lu C, Wang J, Qu J and Tu L: MicroRNA-1/206 targets c-Met and inhibits rhabdomyosarcoma development. J Biol Chem 284: 29596-29604, 2009.
14. Chiyomaru T, Enokida H, Kawakami K, Tatarano S, Uchida Y, Kawahara K, Nishiyama K, Seki N and Nakagawa M: Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer. Urol Oncol: Sep 14, 2011 (Epub ahead of print).
15. Yoshino H, Chiyomaru T, Enokida H, Kawakami K, Tatarano S, Nishiyama K, Nohata N, Seki N and Nakagawa M: The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer. Br J Cancer 104: 808-818, 2011.
16. Ichimi T, Enokida H, Okuno Y, Kunimoto R, Chiyomaru T, Kawamoto K, Kawahara K, Toki K, Kawakami K, Nishiyama K, Tsujimoto G, Nakagawa M and Seki N: Identification of novel microRNA targets based on microRNA signatures in bladder cancer. Int J Cancer 125: 345-352, 2009.
17. Zhang Y, Ye Y, Shen D, Jiang K, Zhang H, Sun W, Zhang J, Xu F, Cui Z and Wang S: Identification of transgelin-2 as a biomarker of colorectal cancer by laser capture microdissection and quantitative proteome analysis. Cancer Sci 101: 523-529, 2010.
18. Nohata N, Hanazawa T, Kikkawa N, Sakurai D, Sasaki K, Chiyomaru T, Kawakami K, Yoshino Y, Enokida H, Nakagawa M, Okamoto Y and Seki N: Identification of novel molecular targets regulated by tumor suppressive miR-1/miR-133a in maxillary sinus squamous cell carcinoma. Int J Oncol 39: 1099-1107, 2011.
19. Kawakami K, Enokida H, Chiyomaru T, Tatarano S, Yoshino H, Kagara I, Gotanda T, Tachiwada T, Nishiyama K, Nohata N, Seki N and Nakagawa M: The functional significance of miR-1 and miR-133a in renal cell carcinoma. Eur J Cancer: Jul 9, 2011 (Epub ahead of print).
20. Kojima S, Chiyomaru T, Kawakami K, Yoshino H, Enokida H, Nohata N, Fuse M, Ichikawa T, Naya Y, Nakagawa M and Seki N: Tumour suppressors miR-1 and miR-133a target the oncogenic function of purine nucleoside phosphorylase (PNP) in prostate cancer. Br J Cancer 106: 405-413, 2012.
21. Sarver AL, French AJ, Borralho PM, Thayanithy V, Oberg AL, Silverstein KA, Morlan BW, Riska SM, Boardman LA, Cunningham JM, Subramanian S, Wang L, Smyrk TC, Rodrigues CM, Thibodeau SN and Steer CJ: Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states. BMC Cancer 9: 401, 2009.
22. Wong TS, Liu XB, Chung-Wai HA, Po-Wing YA, Wai-Man NR and Ignace WW.: Identification of pyruvate kinase type M2 as potential oncoprotein in squamous cell carcinoma of tongue through microRNA profiling. Int J Cancer 123: 251-257, 2008.
23. Rao PK, Missiaglia E, Shields L, Hyde G, Yuan B, Shepherd CJ, Shipley J and Lodish HF: Distinct roles for miR-1 and miR-133a in the proliferation and differentiation of rhambdomyosarcoma cells. FASEB J 24: 3427-3437, 2010.
24. Nohata N, Hanazawa T, Kikkawa N, Mutallip M, Fujimura L, Yoshino H, Kawakami K, Chiyomaru T, Enokida H, Nakagawa M, Okamoto Y and Seki N: Caveolin-1 mediates tumor cell migration and invasion and its regulation by miR-133a in head and neck squamous cell carcinoma. Int J Oncol 38: 209-217, 2011.
25. Mutallip M, Nohata N, Hanazawa T, Kikkawa N, Horiguchi S, Fujimura L, Kawakami K, Chiyomaru T, Enokida H, Nakagawa M, Okamoto Y and Seki N: Gultathione S-transferase P1 (GSTP1) suppresses cell apoptosis and its regulation by miR-133a in head and neck squamous cell carcinoma (HNSCC). Int J Mol Med 27: 345-352, 2011.
26. Jiang X, Kim HE, Shu H, Zhao Y, Zhang H, Kofron J, Donnelly J, Burns D, Nq SC, Rosenberg S and Wang X: Distinctive roles of PHAP proteins and prothymosin-alpha in a death regulatory pathway. Science 299: 223-226, 2003. (Pubitemid 36125203)
27. Abdelmohsen K, Lal A, Kim HH and Gorospe M: Posttranscriptional orchestration of an anti-apoptotic program by HuR. Cell Cycle 6: 1288-1292, 2007. (Pubitemid 47327958)
28. Sasaki H, Nonaka M, Fujii Y, Yamakawa Y, Fukai I, Kiriyama M and Sasaki M: Expression of the prothymosin-α gene as a prognostic factor in lung cancer. Surg Today 31: 936-938, 2001. (Pubitemid 33036173)
29. Wang M, Pan JY, Song GR, Chen HB, An LJ and Qu SX: Altered expression of estrogen receptor alpha and beta in advanced gastric adenocarcinoma: correlation with prothymosin alpha and clinicopathological parameters. Eur J Surg Oncol 33: 195-201, 2007. (Pubitemid 46336548)
30. Letsas KP, Frangou-Lazaridis M, Skyrlas A, Tsatsoulis A and Malamou-Mitsi V: Transcription factor-mediated proliferation and apoptosis in benign and malignant thyroid lesions. Pathol Int 55: 694-702, 2005. (Pubitemid 41726935)
31. Wu CG, Habib NA, Mitry RR, Reitsma PH, van Deventer SJ and Chamuleau RA: Overexpression of hepatic prothymosin alpha, a novel marker for human hepatocellular carcinoma. Br J Cancer 76: 1199-1204, 1997. (Pubitemid 27448017)
32. Gou LT, Tong AP, Yan F, Yuan Z, He F, Wang W, Zhou Y, Chen LJ, Tang MH and Yang JL: Altered protein-expressing profile in hPNAS4-induced apoptosis in A549 human lung adenocarcinoma cells. J Cell Biochem 108: 1211-1219, 2009.
33. Balakrishnan K, Verma D, O'Brien S, Kilpatrick JM, Chen Y, Tyler BF, Bickel S, Bantia S, Keating MJ, Kantarjian H, Ghandhi V and Ravandi F: Phase 2 and pharmacodynamic study of oral forodesine in patients with advanced, fludarabine-treated chronic lymphocytic leukemia. Blood 116: 886-892, 2010.
34. Alonso R, Lopez-Guerra M, Upshaw R, Bantia S, Smal C, Bontemps F, Manz C, Mehrling T, Villamor N, Campo E, Montserrat E and Colomer D: Forodesine has high antitumor activity in chronic lymphocytic leukemia and activates p53-independent mitochondrial apoptosis by induction of p73 and BIM. Blood 114: 1563-1575, 2009.